WO2000007571A3 - Formulations renfermant des micro-organismes a effet probiotique - Google Patents

Formulations renfermant des micro-organismes a effet probiotique Download PDF

Info

Publication number
WO2000007571A3
WO2000007571A3 PCT/AT1999/000192 AT9900192W WO0007571A3 WO 2000007571 A3 WO2000007571 A3 WO 2000007571A3 AT 9900192 W AT9900192 W AT 9900192W WO 0007571 A3 WO0007571 A3 WO 0007571A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulations
active microorganisms
microorganisms
probiotically active
probiotically
Prior art date
Application number
PCT/AT1999/000192
Other languages
German (de)
English (en)
Other versions
WO2000007571A2 (fr
Inventor
Helmut Viernstein
Original Assignee
Helmut Viernstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmut Viernstein filed Critical Helmut Viernstein
Priority to EP99938048A priority Critical patent/EP1102580A2/fr
Priority to AU52704/99A priority patent/AU5270499A/en
Publication of WO2000007571A2 publication Critical patent/WO2000007571A2/fr
Publication of WO2000007571A3 publication Critical patent/WO2000007571A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une formulation renfermant des micro-organismes stabilisés et des substances tampon. Cette formulation facilite le passage des micro-organismes, après leur dispersion et leur absorption dans le tube digestif, à travers l'estomac, tout en maintenant leur vitalité.
PCT/AT1999/000192 1998-08-06 1999-07-29 Formulations renfermant des micro-organismes a effet probiotique WO2000007571A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99938048A EP1102580A2 (fr) 1998-08-06 1999-07-29 Formulations renfermant des micro-organismes a effet probiotique
AU52704/99A AU5270499A (en) 1998-08-06 1999-07-29 Formulations having probiotically active microorganisms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA1360/98 1998-08-06
AT0136098A AT407008B (de) 1998-08-06 1998-08-06 Formulierungen mit probiotisch wirksamen mikroorganismen

Publications (2)

Publication Number Publication Date
WO2000007571A2 WO2000007571A2 (fr) 2000-02-17
WO2000007571A3 true WO2000007571A3 (fr) 2000-05-11

Family

ID=3512210

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT1999/000192 WO2000007571A2 (fr) 1998-08-06 1999-07-29 Formulations renfermant des micro-organismes a effet probiotique

Country Status (4)

Country Link
EP (1) EP1102580A2 (fr)
AT (1) AT407008B (fr)
AU (1) AU5270499A (fr)
WO (1) WO2000007571A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
EP1303285A2 (fr) * 2000-07-17 2003-04-23 Chr. Hansen A/S Procede et formulations avec des microorganismes probiotiques et medicaments
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1287745A1 (fr) 2001-08-24 2003-03-05 The Procter & Gamble Company Composition masicatoire avec des substances probiotiques
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
DK2318511T3 (en) * 2008-08-28 2017-09-25 Chr Hansen As bacterial Preparation
MX2011008755A (es) 2009-02-23 2011-09-09 Chr Hansen As Metodo para elaborar una composicion de bacterias de acido lactico.
FR2963239B1 (fr) * 2010-08-02 2013-03-08 Vetalis Formes galeniques effervescentes solides pour animaux
JP2013537531A (ja) 2010-08-04 2013-10-03 トーマス・ジュリアス・ボロディ 糞便細菌叢移植のための組成物ならびにそれを作製および使用する方法ならびにそれを送達するためのデバイス
TR201007613A2 (tr) * 2010-09-16 2012-04-24 Yed�Tepe �N�Vers�Tes� Liyofilize biyopestisit efervesan granül ve üretim yöntemi
AU2012225305B2 (en) 2011-03-09 2017-06-08 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
WO2013176774A1 (fr) 2012-05-25 2013-11-28 Arizona Board Of Regents Marqueurs de microbiome et thérapies pour troubles du spectre autistique
CN103550401B (zh) * 2013-11-19 2016-06-22 浙江美保龙生物技术有限公司 一种复合微生态制剂泡腾片的制备方法
AU2015245942A1 (en) * 2014-04-09 2016-10-20 Kambouris Shares Pty Ltd Methods and compositions for delivering a probiotic
KR102561989B1 (ko) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
CN108243608A (zh) 2015-05-22 2018-07-03 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (fr) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions et méthodes pour traiter la maladie de parkinson (pd) et des troubles associés
CA3064773A1 (fr) 2017-05-26 2018-11-29 Crestovo Holdings Llc Compositions lyophilisees comprenant des agents therapeutiques a base de microbes fecaux et leurs procedes de fabrication et d'utilisation
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
EP0393909A1 (fr) * 1989-04-13 1990-10-24 Beecham Group p.l.c. Composition
WO1994018997A1 (fr) * 1993-02-24 1994-09-01 Valio Ltd. Procede d'amelioration de la reponse immunitaire aux vaccins oraux
WO1997016198A1 (fr) * 1995-11-02 1997-05-09 Chr. Hansen Biosystems A/S Formulation a effet probiotique
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
FR2770778A1 (fr) * 1997-11-12 1999-05-14 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3626M (fr) * 1963-11-13 1965-10-18 Lucien Nouvel Médicament pour affections intestinales.
FI840816A0 (fi) * 1984-03-01 1984-03-01 Farmos Oy Bakteriepreparat
GR861387B (en) * 1985-05-29 1986-10-02 Pioneer Hi Bred Int Method of treating gastrointestinal disease in animals
DE4033996A1 (de) * 1990-10-25 1992-04-30 Karl Heinz Hoelzel Enzymatisches stoffwechselprodukt zur symbioselenkung und verfahren zu seiner herstellung
US5340577A (en) * 1992-07-29 1994-08-23 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
EP0393909A1 (fr) * 1989-04-13 1990-10-24 Beecham Group p.l.c. Composition
WO1994018997A1 (fr) * 1993-02-24 1994-09-01 Valio Ltd. Procede d'amelioration de la reponse immunitaire aux vaccins oraux
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
WO1997016198A1 (fr) * 1995-11-02 1997-05-09 Chr. Hansen Biosystems A/S Formulation a effet probiotique
FR2770778A1 (fr) * 1997-11-12 1999-05-14 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GIROLA M ET AL: "Efficacy of probiotic preparation with living, freeze-dried lactic acid bacteria and yeast on child diarrhoea", ARCHIVIO DI MEDICINA INTERNA, 1995, pages 62 - 72, XP002035135 *

Also Published As

Publication number Publication date
AT407008B (de) 2000-11-27
WO2000007571A2 (fr) 2000-02-17
EP1102580A2 (fr) 2001-05-30
ATA136098A (de) 2000-04-15
AU5270499A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
WO2000007571A3 (fr) Formulations renfermant des micro-organismes a effet probiotique
AU2001252513A1 (en) Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
AU1232600A (en) Dosage forms containing taste masked active agents
EP1642506A3 (fr) Utilisation de subtilisines stables en milieu acide dans des aliments pour animaux
AU2487699A (en) Alteration of amino acid compositions in seeds
AU6076198A (en) Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
AU2001252169A1 (en) Combinations of active ingredients with insecticidal and acaricidal properties
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
WO2001041785A3 (fr) Traitement enzymatique des infections
WO2002056712A3 (fr) Acide organique metallate fortement acide utilise comme additif alimentaire
HUP9701437A3 (en) Use of complex lipides as stabilizing additives in pharmaceutical compositions containing digestive enzymes, pharmaceutical compns. and kits
AU2002342907A1 (en) Gel capsules containing active ingredients and use thereof
WO2000074712A3 (fr) Composition renfermant de la sphingomyelinase alcaline utilisee comme preparation dietetique, complement alimentaire ou produit pharmaceutique
WO2003053180A3 (fr) Sous-vetements contenant des principes actifs
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
FR2827774B1 (fr) Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
AU1275401A (en) Fibrous-liponutritional complexes and compositions containing them
WO2003007733A8 (fr) Denree alimentaire contenant des proteines comprenant une enzyme de reticulation et un hydrocolloide
AU6213699A (en) Nutritional and pharmaceutical compositions
AU2001275144A1 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
AU2511997A (en) Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU5816298A (en) Taste masking for unpalatable formulations
HK1045937A1 (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
AU2001230543A1 (en) Physiologically active compositions based upon active ingredients of basidiomycotina and araliaceae

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999938048

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999938048

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999938048

Country of ref document: EP